Search research articles
Contact Us
Filters
Showing results (151-160 of 191) with videos related to
Page
of 20
Sort By:
Journal of the American College of Cardiology
|
May 22, 2002
Intramural coronary delivery of advanced antisense oligonucleotides reduces neointimal formation in the porcine stent restenosis model
Nicholas N Kipshidze, Han Soo Kim, Patrick Iversen, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)
|
May 17, 2022
SARS-CoV-2 Kappa Variant Shows Pathogenicity in a Syrian Hamster Model
Pragya D Yadav, Sreelekshmy Mohandas, Anita M Shete, et al.
Indian Dermatology Online Journal
|
October 3, 2024
Development of Indian Council of Medical Research (ICMR) Standard Treatment Workflows for Skin Diseases: A Step Toward Universal Health Coverage
Ananta Khurana, Ashoo Grover, Deepika Pandhi, et al.
Journal of Travel Medicine
|
March 4, 2022
Immune responses against different variants of SARS-CoV-2 including Omicron following 6 months of administration of heterologous prime-boost COVID-19 vaccine
Gajanan Sapkal, Rajni Kant, Gaurav Dwivedi, et al.
JACC. Cardiooncology
|
November 8, 2021
Concomitant Transthyretin Amyloidosis and Severe Aortic Stenosis in Elderly Indian Population: A Pilot Study
Aayush Kumar Singal, Raghav Bansal, Avinainder Singh, et al.
The Indian Journal of Medical Research
|
July 21, 2022
Development of the India COVID-19 vaccine tracker
Harpreet Singh, Rohan Lohia, Leyanna Susan George, et al.
Global Heart
|
March 25, 2024
India Hypertension Control Initiative: Blood Pressure Control Using Drug and Dose-Specific Standard Treatment Protocol at Scale in Punjab and Maharashtra, India, 2022
Prabhdeep Kaur, Manikandanesan Sakthivel, Vettrichelvan Venkatasamy, et al.
The Lancet. Infectious Diseases
|
January 24, 2021
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial
Raches Ella, Krishna Mohan Vadrevu, Harsh Jogdand, et al.
The New England Journal of Medicine
|
December 2, 2020
Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them
, Philip R Krause, Thomas R Fleming, et al.
Iscience
|
February 1, 2021
Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster model
Sreelekshmy Mohandas, Pragya D Yadav, Anita Shete-Aich, et al.
Page
of 20
Search research articles
Search
Showing results (151-160 of 191) with videos related to
Sort By:
Page
of 20
Journal of the American College of Cardiology
|
May 22, 2002
Intramural coronary delivery of advanced antisense oligonucleotides reduces neointimal formation in the porcine stent restenosis model
Nicholas N Kipshidze, Han Soo Kim, Patrick Iversen, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)
|
May 17, 2022
SARS-CoV-2 Kappa Variant Shows Pathogenicity in a Syrian Hamster Model
Pragya D Yadav, Sreelekshmy Mohandas, Anita M Shete, et al.
Indian Dermatology Online Journal
|
October 3, 2024
Development of Indian Council of Medical Research (ICMR) Standard Treatment Workflows for Skin Diseases: A Step Toward Universal Health Coverage
Ananta Khurana, Ashoo Grover, Deepika Pandhi, et al.
Journal of Travel Medicine
|
March 4, 2022
Immune responses against different variants of SARS-CoV-2 including Omicron following 6 months of administration of heterologous prime-boost COVID-19 vaccine
Gajanan Sapkal, Rajni Kant, Gaurav Dwivedi, et al.
JACC. Cardiooncology
|
November 8, 2021
Concomitant Transthyretin Amyloidosis and Severe Aortic Stenosis in Elderly Indian Population: A Pilot Study
Aayush Kumar Singal, Raghav Bansal, Avinainder Singh, et al.
The Indian Journal of Medical Research
|
July 21, 2022
Development of the India COVID-19 vaccine tracker
Harpreet Singh, Rohan Lohia, Leyanna Susan George, et al.
Global Heart
|
March 25, 2024
India Hypertension Control Initiative: Blood Pressure Control Using Drug and Dose-Specific Standard Treatment Protocol at Scale in Punjab and Maharashtra, India, 2022
Prabhdeep Kaur, Manikandanesan Sakthivel, Vettrichelvan Venkatasamy, et al.
The Lancet. Infectious Diseases
|
January 24, 2021
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial
Raches Ella, Krishna Mohan Vadrevu, Harsh Jogdand, et al.
The New England Journal of Medicine
|
December 2, 2020
Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them
, Philip R Krause, Thomas R Fleming, et al.
Iscience
|
February 1, 2021
Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster model
Sreelekshmy Mohandas, Pragya D Yadav, Anita Shete-Aich, et al.
Page
of 20